Dr. Krasner is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
194 Howard St.
New London, CT 06320Phone+1 860-444-3366- Is this information wrong?
Education & Training
- Johns Hopkins UniversityFellowship, Endocrinology, Diabetes, and Metabolism, 1991 - 1994
- Johns Hopkins UniversityResidency, Internal Medicine, 1988 - 1991
- Northwestern University The Feinberg School of MedicineClass of 1988
Certifications & Licensure
- CA State Medical License 2021 - 2025
- CT State Medical License 2000 - 2018
Publications & Presentations
PubMed
- 22 citationsDevelopment of Stable Liquid Glucagon Formulations for Use in Artificial PancreasRoderike Pohl, Ming Li, Alan Krasner, Errol De Souza> ;Journal of Diabetes Science and Technology. 2015 Jan 1
- 32 citationsA Review of a Family of Ultra-Rapid-Acting Insulins: Formulation Development:Alan Krasner, Roderike Pohl, Patrick Simms, Philip Pichotta, Robert Hauser, Errol De Souza> ;Journal of Diabetes Science and Technology. 2012 Jul 1
- U-100, pH-Neutral formulation of VIAject(®) : faster onset of action than insulin lispro in patients with type 1 diabetes.Heinemann L, Nosek L, Flacke F, Albus K, Krasner A, Pichotta P, Heise T, Steiner S> ;Diabetes Obes Metab. 2012-03-01
- Join now to see all
Press Mentions
- Crinetics Pharmaceuticals Presenting New Data from Open Label Extension Trial of Paltusotine in Acromegaly at the Society for Endocrinology BES CongressNovember 8th, 2021
- $-0.40 EPS Expected for Crinetics Pharmaceuticals, Inc. (CRNX)December 14th, 2018
Hospital Affiliations
- Lawrence + Memorial HospitalNew London, Connecticut
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: